HSP90AA1 and autoimmune bullous skin disease: Very recently, using mice with experimental epidermolysis bullosa acquisita, we were able to show that inhibition of Hsp90 is associated with amelioration of clinical signs, suppression of autoantibody production and reduction of inflammatory skin infiltrate in this autoimmune bullous skin disease [10].